Atai prunes pipeline, drops out of part­ner­ships as it takes on $175M loan and fo­cus­es on loom­ing da­ta read­outs

Plan­ning for the long haul, men­tal health-fo­cused biotech atai Life Sci­ences has tak­en a hard look at its siz­able port­fo­lio — and de­cid­ed to cut off parts of it.

The de­ci­sion to stop fund­ing cer­tain pro­grams and dis­cov­ery ef­forts, de­scribed as a “com­pa­ny-wide cost op­ti­miza­tion,” should lead to “sig­nif­i­cant cost sav­ings,” not­ed CEO Flo­ri­an Brand. At the same time, he’s pulling in $175 mil­lion through a term loan fa­cil­i­ty from Her­cules Cap­i­tal, a move that should ex­tend the cash run­way to 2025.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER